Open AccessS204: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA WITH SLOW EARLY RESPONSE TO FRONTLINE CHEMOTHERAPY: THE PHASE 2, OPEN‐LABEL, KEYNOTE‐667 STUDY
Author(s) -
Vinti L.,
Daw S.,
Sabado Alvarez C.,
Fagioli F.,
Beishuizen A.,
Michel G.,
Moleti M. L.,
Cepelova M.,
Thorwarth A.,
Rigaud C.,
Plaza Lopez de Sabando D.,
Landman Parker J.,
Zhu Y.,
Pillai P.,
Nahar A.,
MauzKoerholz C.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843708.43092.96
Subject(s) - medicine , vincristine , pembrolizumab , dacarbazine , prednisone , cyclophosphamide , chemotherapy , radiation therapy , oncology , surgery , cancer , immunotherapy